Out on PubMed is this letter-to-the-editor from JECT:

Rakesh G, Mischel NA, Gunderson-Falcone G, Anderson A, Copeland D, Szabo ST, Weiner RD.
ECT. 2020 Mar 31. doi: 10.1097/YCT.0000000000000679. [Epub ahead of print] No abstract available. 
PMID:
 
32243338

The pdf is here.

These investigators, most of whom are from Duke, present a pilot study with 10 patients, testing augmentation of ECT with bupropion.
The idea is that concomitant use of an antidepressant might enhance/speed up antidepressant effect, and that, additionally, a putative pro-convulsant antidepressant might enhance seizure quality.
The results were inconclusive, but the authors suggest that a larger trial is warranted, and they are probably correct.

Comments

Popular posts from this blog

ECT vs Ketamine: NEJM Article Sets Up False Equivalency

RUL ECT vs Low Amplitude Seizure Therapy (LAP-ST)

ECT For Children at a University Hospital: New Study in JECT